Genetic basis of host resistance to norovirus infection

Future Virology

Volumn 4, Issue 4, 2009, Pages 369-382

  Kindberg, Elin ^a   Svensson, Lennart ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Gastroenteritis; Histo blood group antigens; Host genetics; Norovirus; Secretor status; Susceptibility; Viral evolution

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; FUCOSYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ACUTE GASTROENTERITIS; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; BRAIN DISEASE; CHROMOSOME 19; DIARRHEA; EPIDEMIC; ETHNICITY; FRAMESHIFT MUTATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMAGGLUTINATION; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; INTESTINE VILLUS ATROPHY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; NONSENSE MUTATION; NOROVIRUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS TRANSMISSION; VOMITING; WINTER VOMITING DISEASE;

NOROVIRUS;

EID: 70350092384     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.09.14     Document Type: Review

References (105)

1. Casanova JL, Abel L: Primary immunodeficiencies: a field in its infancy. Science 317, 617-619 (2007).
2. Brown KE, Hibbs JR, Gallinella G et al.: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330, 1192-1196 (1994).
3. Dean M, Carrington M, Winkler C et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development study, Multicenter AIDS Cohort study, Multicenter Hemophilia Cohort study, San Francisco City Cohort, ALIVE study. Science 273, 1856-1862 (1996).
4. Glass WG, McDermott DH, Lim JK et al.: CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203, 35-40 (2006).
5. Kindberg E, Mickiene A, Ax C et al.: A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J. Infect. Dis. 197, 266-269 (2008).
6. Picard C, Casanova JL, Abel L: Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18, 383-390 (2006).
7. Atmar RL, Estes MK: The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. North Am. 35, 275-290, viii (2006).
8. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS: Norovirus classification and proposed strain nomenclature. Virology 346, 312-323 (2006).
9. Lopman B, Vennema H, Kohli E et al.: Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363, 682-688 (2004).
10. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA: Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J. Clin. Microbiol. 44, 327-333 (2006).
11. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM: Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10, 1075-1081 (1972).
12. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD: Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14, 1224-1231 (2008).
13. Rockx B, De Wit M, Vennema H et al.: Natural history of human calicivirus infection: a prospective cohort study. Clin. Infect. Dis. 35, 246-253 (2002).
14. Nilsson M, Hedlund KO, Thorhagen M et al.: Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J. Virol. 77, 13117-13124 (2003).
15. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M: Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin. Microbiol. Infect. 12, 69-74 (2006).
16. Ludwig A, Adams O, Laws HJ, Schroten H, Tenenbaum T: Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J. Med. Virol. 80, 1461-1467 (2008).
17. Gallimore CI, Lewis D, Taylor C, Cant A, Gennery A, Gray JJ: Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). J. Clin. Virol. 30, 196-204 (2004).
18. Dolin R, Blacklow NR, DuPont H et al.: Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J. Infect. Dis. 123, 307-312 (1971).
19. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB: Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 161, 18-21 (1990).
20. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR: Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297, 86-89 (1977).
21. Schreiber DS, Blacklow NR, Trier JS: The small intestinal lesion induced by Hawaii agent acute infectious nonbacterial gastroenteritis. J. Infect. Dis. 129, 705-708 (1974).
22. Wyatt RG, Dolin R, Blacklow NR et al.: Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 129, 709-714 (1974).
23. Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS: Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann. Intern. Med. 79, 18-25 (1973).
24. Schreiber DS, Blacklow NR, Trier JS: The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med. 288, 1318-1323 (1973).
25. Widerlite L, Trier JS, Blacklow NR, Schreiber DS: Structure of the gastric mucosa in acute infectious bacterial gastroenteritis. Gastroenterology 68, 425-430 (1975).
26. Meeroff JC, Schreiber DS, Trier JS, Blacklow NR: Abnormal gastric motor function in viral gastroenteritis. Ann. Intern. Med. 92, 370-373 (1980).
27. Troeger H, Loddenkemper C, Schneider T et al.: Structural and functional changes of the duodenum in human norovirus infection. Gut (2008) (Epub ahead of print).
28. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L: Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287, 491-495 (2000).
29. Kordasti S, Sjovall H, Lundgren O, Svensson L: Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut 53, 952-957 (2004).
30. Ito S, Takeshita S, Nezu A et al.: Norovirus-associated encephalopathy. Pediatr. Infect. Dis. J. 25, 651-652 (2006).
31. Centers for Disease Control and Prevention. Outbreak of acute gastroenteritis associated with Norwalk-like viruses among British military personnel, Afghanistan, May 2002. Morb. Mortal. Wkly Rep. 51, 477-479 (2002).
32. Takanashi S, Hashira S, Matsunaga T et al.: Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J. Clin. Virol. 44, 161-163 (2009).
33. Noda M, Fukuda S, Nishio O: Statistical analysis of attack rate in norovirus foodborne outbreaks. Int. J. Food Microbiol. 122, 216-220 (2008).
34. Larsson MM, Rydell GE, Grahn A et al.: Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J. Infect. Dis. 194, 1422-1427 (2006).
35. Ruvoën-Clouet N, Ganière JP, André-Fontaine G, Blanchard D, Le Pendu J: Binding of rabbit hemorrhagic disaese virus to antigens of the ABH histo-blood group family. J. Virol. 74, 11950-11954 (2000).
36. Le Pendu J, Ruvoen-Clouet N, Kindberg E, Svensson L: Mendelian resistance to human norovirus infections. Semin. Immunol. 18, 375-386 (2006).
37. Hutson AM, Airaud F, LePendu J, Estes MK, Atmar RL: Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 77, 116-120 (2005).
38. Kindberg E, Akerlind B, Johnsen C et al.: Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J. Clin. Microbiol. 45, 2720-2722 (2007).
39. Lindesmith L, Moe C, Marionneau S et al.: Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548-553 (2003).
40. Thorven M, Grahn A, Hedlund KO et al.: A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79, 15351-15355 (2005).
41. Tan M, Jin M, Xie H, Duan Z, Jiang X, Fang Z: Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J. Med. Virol. 80, 1296-1301 (2008).
42. Bucardo F, Kindberg E, Paniagua M, Vildevall M, Svensson L: Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J. Med. Virol. 81, 728-735 (2009).
43. 1,2-fucosyltransferase gene (FUT2): homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the nonsecretor phenotype. J. Biol. Chem. 270, 4640-4649 (1995).
44. a+b+ phenotype: a potential molecular basis for the weak Secretor allele (Sew). Biochem. J. 312(Pt 2), 329-332 (1995).
45. 1,2-fucosyltransferase activity. Glycoconj. J. 13, 985-993 (1996).
46. Henry S, Mollicone R, Lowe JB, Samuelsson B, Larson G: A second nonsecretor allele of the blood group α1,2-fucosyl-transferase gene (FUT2). Vox Sang. 70, 21-25 (1996).
47. Koda Y, Soejima M, Kimura H: The polymorphisms of fucosyltransferases. Leg. Med. (Tokyo) 3, 2-14 (2001).
48. Rydell GE, Nilsson J, Rodriguez-Diaz J et al.: Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 19, 309-320 (2009).
49. Shirato H, Ogawa S, Ito H et al.: Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 82, 10756-10767 (2008).
50. Marionneau S, Ruvoen N, Le Moullac-Vaidye B et al.: Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967-1977 (2002).
51. Hutson AM, Airaud F, Le Pendu J, Estes MK, Atmar RL: Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 77, 116-120 (2005).
52. Bucardo F, Nordgren J, Carlsson B et al.: Pediatric norovirus diarrhea in Nicaragua. J. Clin. Microbiol. 46, 2573-2580 (2008).
53. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS: Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79, 2900-2909 (2005).
54. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP: Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis. 191, 749-754 (2005).
55. Hutson AM, Atmar RL, Graham DY, Estes MK: Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 185, 1335-1337 (2002).
56. Hennessy EP, Green AD, Connor MP, Darby R, MacDonald P: Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 188, 176-177 (2003).
57. Fretz R, Svoboda P, Schorr D, Tanner M, Baumgartner A: Risk factors for infections with norovirus gastrointestinal illness in Switzerland. Eur. J. Clin. Microbiol. Infect. Dis. 24, 256-261 (2005).
58. Meyer E, Ebner W, Scholz R, Dettenkofer M, Daschner FD: Nosocomial outbreak of norovirus gastroenteritis and investigation of ABO histo-blood group type in infected staff and patients. J. Hosp. Infect. 56, 64-66 (2004).
59. Miyoshi M, Yoshizumi S, Sato C, Okui T, Ogawa H, Honma H: [Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study]. Kansenshḡaku Zasshi 79, 664-671 (2005).
60. Tan M, Jiang X: Norovirus-host interaction: implications for disease control and prevention. Expert Rev. Mol. Med. 9, 1-22 (2007).
61. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoen-Clouet N: Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J. Infect. Dis. 192, 1071-1077 (2005).
62. Halperin T, Vennema H, Koopmans M et al.: No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J. Infect. Dis. 197, 63-65 (2008).
63. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS: Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76, 12335-12343 (2002).
64. Huang P, Farkas T, Marionneau S et al.: Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 188, 19-31 (2003).
65. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK: Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85, 79-87 (2004).
66. Jiang X, Wang M, Graham DY, Estes MK: Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66, 6527-6532 (1992).
67. Huang P, Farkas T, Zhong W et al.: Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714-6722 (2005).
68. Olofsson S, Bergstrom T: Glycoconjugate glycans as viral receptors. Ann. Med. 37, 154-172 (2005).
69. Harrington PR, Vinje J, Moe CL, Baric RS: Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 78, 3035-3045 (2004).
70. Cao S, Lou Z, Tan M et al.: Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81, 5949-5957 (2007).
71. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK: X-ray crystallographic structure of the Norwalk virus capsid. Science 286, 287-290 (1999).
72. Choi JM, Hutson AM, Estes MK, Prasad BV: Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl Acad. Sci. USA 105, 9175-9180 (2008).
73. Bu W, Mamedova A, Tan M, Xia M, Jiang X, Hegde RS: Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 82, 5340-5347 (2008).
74. Tan M, Xia M, Chen Y et al.: Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS ONE 4, e5058 (2009).
75. Bull RA, Tanaka MM, White PA: Norovirus recombination. J. Gen. Virol. 88, 3347-3359 (2007).
76. Domingo E, Baranowski E, Ruiz-Jarabo CM, Martin-Hernandez AM, Saiz JC, Escarmis C: Quasispecies structure and persistence of RNA viruses. Emerg. Infect. Dis. 4, 521-527 (1998).
77. Domingo E, Holland JJ: RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151-178 (1997).
78. Carlsson B, Lindberg AM, Rodriguez-Diaz J, Hedlund KO, Persson B, Svensson L: Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection. J. Gen. Virol. 90, 432-441 (2009).
79. Siebenga JJ, Vennema H, Renckens B et al.: Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 81, 9932-9941 (2007).
80. Lindesmith LC, Donaldson EF, Lobue AD et al.: Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5, e31 (2008).
81. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS: Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol. Rev. 225, 190-211 (2008).
82. Gallimore CI, Green J, Lewis D et al.: Diversity of noroviruses cocirculating in the north of England from 1998 to 2001. J. Clin. Microbiol. 42, 1396-1401 (2004).
83. Blanton LH, Adams SM, Beard RS et al.: Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J. Infect. Dis. 193, 413-421 (2006).
84. Kroneman A, Verhoef L, Harris J et al.: Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the foodborne viruses in Europe Network from 1 July 2001 to 30 June 2006. J. Clin. Microbiol. 46, 2959-2965 (2008).
85. Siebenga JJ, Vennema H, Duizer E, Koopmans MP: Gastroenteritis caused by norovirus GGII.4, The Netherlands, 1994-2005. Emerg. Infect. Dis. 13, 144-146 (2007).
86. Allen DJ, Gray JJ, Gallimore CI, Xerry J, Iturriza-Gomara M: Analysis of amino acid variation in the P2 domain of the GII.4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS ONE 3, e1485 (2008).
87. Chakravarty S, Hutson AM, Estes MK, Prasad BV: Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J. Virol. 79, 554-568 (2005).
88. Pang H, Fujitani N, Soejima M et al.: Two distinct Alu-mediated deletions of the human ABO-secretor (FUT2) locus in Samoan and Bangladeshi populations. Hum. Mutat. 16, 274 (2000).
89. 1,2-fucosyltransferase gene mutations in the Chinese and Thai populations. Transfusion 39, 1013-1017 (1999).
90. Liu Y, Koda Y, Soejima M et al.: Extensive polymorphism of the FUT2 gene in an African (Xhosa) population of South Africa. Hum. Genet. 103, 204-210 (1998).
91. 1,2-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am. J Hum. Genet. 59, 343-350 (1996).
92. 1,2-fucosyltransferase gene deficiency in the Philippine population. Ann. Hematol. 78, 463-467 (1999).
93. Liu YH, Koda Y, Soejima M et al.: The fusion gene at the ABO-secretor locus (FUT2): absence in Chinese populations. J. Hum. Genet. 44, 181-184 (1999).
94. Koda Y, Soejima M, Johnson PH, Smart E, Kimura H: Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system. Biochem. Biophys. Res. Commun. 238, 21-25 (1997).
95. Fernandez-Mateos P, Cailleau A, Henry S et al.: Point mutations and deletion responsible for the Bombay H null and the Reunion H weak blood groups. Vox Sang. 75, 37-46 (1998).
96. Koda Y, Soejima M, Johnson PH, Smart E, Kimura H: An Alu-mediated large deletion of the FUT2 gene in individuals with the ABO-Bombay phenotype. Hum. Genet. 106, 80-85 (2000).
97. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR: Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N. Engl. J. Med. 320, 773-777 (1989).
98. Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE: Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J. Clin. Invest. 90, 965-972 (1992).
99. Blackwell CC, Jonsdottir K, Hanson MF, Weir DM: Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 2, 687 (1986).
100. Blackwell CC, Jonsdottir K, Hanson M et al.: Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 2, 284-285 (1986).
101. Raza MW, Blackwell CC, Molyneaux P et al.: Association between secretor status and respiratory viral illness. BMJ 303, 815-818 (1991).
102. Ali S, Niang MA, N'Doye I et al.: Secretor polymorphism and human immunodeficiency virus infection in Senegalese women. J. Infect. Dis. 181, 737-739 (2000).
103. Blackwell CC, James VS, Davidson S et al.: Secretor status and heterosexual transmission of HIV. BMJ 303, 825-826 (1991).
104. Kindberg E, Hejdeman B, Bratt G et al.: A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS 20, 685-689 (2006).
105. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK: Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170, 34-43 (1994).